# Can ARA-290 protect against oxidative stress in aging tissues?

Canonical source: https://retacompare.com/research/can-ara-290-protect-against-oxidative-stress-in-aging-tissues

Peptide Longevity Q&A · 2020-08-01


    Research indicates that ARA-290 can act as a protective agent against oxidative stress and DNA damage induced by doxorubicin (DOX). It significantly reduces oxidative damage and inflammation, suggesting potential benefits for aging tissues that are susceptible to such stressors.

 What the research shows

The study investigated the effects of ARA-290, a non-erythropoietic peptide derived from erythropoietin, on the cytotoxicity, genotoxicity, and oxidative stress induced by doxorubicin in vitro. The research was conducted using three different cell lines: HepG2, human gingival fibroblasts (HGF), and stem cells. Cells were treated with varying concentrations of ARA-290 and a fixed dose of DOX. Cytotoxicity was assessed using the MTT assay, while genoprotective effects were evaluated through the micronucleus test and comet assay. The findings showed that ARA-290 significantly reduced DNA damage and oxidative stress caused by DOX.

 Why it matters for longevity

Oxidative stress and inflammation are key contributors to aging and age-related diseases. As tissues age, their ability to cope with oxidative damage diminishes, leading to cellular dysfunction and increased susceptibility to various diseases. ARA-290's ability to mitigate oxidative stress and inflammation could have significant implications for preserving tissue integrity and function in aging individuals. By potentially protecting against DNA damage and enhancing cellular resilience, ARA-290 may contribute to improved healthspan and longevity.

 Key findings at a glance

ARA-290 is a non-erythropoietic peptide derived from erythropoietin.

The study assessed the protective effects of ARA-290 against doxorubicin-induced toxicity.

ARA-290 significantly reduced DNA damage in treated cells.

The peptide attenuated oxidative stress and inflammation caused by doxorubicin.

Results suggest ARA-290 may protect various cell types, including potentially cardiac cells.

 How ARA-290 works (background)

ARA-290 interacts selectively with the innate repair receptor, exhibiting anti-inflammatory, anti-apoptotic, and cytoprotective properties similar to erythropoietin, but without its hematopoietic side effects. In the context of oxidative stress, ARA-290 may enhance antioxidant defenses, reduce inflammation, and promote cellular repair mechanisms. This mechanism of action positions ARA-290 as a candidate for protecting tissues from damage associated with aging and chemotherapy.

 Safety, caveats, and what we don't yet know

While the findings are promising, it is important to note that the study was conducted in vitro, and further research is needed to confirm these effects in vivo. The long-term safety and efficacy of ARA-290 in human populations, particularly among older adults or those with chronic conditions, have not been thoroughly investigated. Additionally, the specific mechanisms through which ARA-290 exerts its protective effects are still being explored, and more studies are needed to fully understand its potential applications in aging and longevity.

 Bottom line

ARA-290 shows potential as a protective agent against oxidative stress and DNA damage, which are significant factors in aging. Its ability to reduce inflammation and enhance cellular resilience may contribute to improved healthspan.

 Related questions

 Does ARA-290 have benefits for heart health in aging?

Research suggests that ARA-290 may protect cardiac cells from oxidative stress, which is crucial for heart health as individuals age. Further studies are needed to explore its specific effects on heart function.

 Can ARA-290 aid in recovery from chemotherapy?

ARA-290 has shown potential in reducing the genotoxicity and oxidative stress associated with doxorubicin, indicating it may aid recovery from chemotherapy-induced damage. More research is required to confirm these benefits in clinical settings.

 What role does ARA-290 play in tissue repair?

ARA-290's interaction with the innate repair receptor suggests it may enhance tissue repair mechanisms, particularly in the context of oxidative damage. This could have implications for regenerative medicine and age-related tissue degeneration.

 Source: PubMed · Toxicol In Vitro · published 2020-08-01.

## Sources

- PubMed · Toxicol In Vitro: https://pubmed.ncbi.nlm.nih.gov/32335150/